Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1988
Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemiaR Viray, P Turlapaty, A LadduAmerican Heart Journal|February 1, 1985
Comparison of acebutolol and propranolol in essential hypertensionJ Wahl, P Turlapaty, B N SinghAmerican Heart Journal|January 1, 1986
Clinical electrophysiology of flestolol, a potent ultra short-acting beta blockerC D Swerdlow, J Peterson, P TurlapatyThe American Journal of Cardiology|October 23, 1985
Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmiaJ Morganroth, L N Horowitz, J Anderson, et al.Journal of Clinical Pharmacology|March 1, 1986
Flestolol: an ultra-short-acting beta-adrenergic blocking agentS D Barton, J Burge, P Turlapaty, et al.American Heart Journal|October 1, 1987
Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settingsP Turlapaty, A Laddu, V S Murthy, et al.Journal of Clinical Pharmacology|March 1, 1986
Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemiaR J Sung, L Blanski, J Kirshenbaum, et al.Journal of Clinical Pharmacology|August 1, 1987
Hemodynamic effects of esmolol, an ultrashort-acting beta blockerJ Askenazi, P E MacCosbe, J Hoff, et al.Clinical Pharmacology and Therapeutics|May 1, 1986
Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blockerP Turlapaty, J Burge, J Hulse, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1990
Nicardipine in severe hypertension: oral therapy following intravenous treatmentJ D Wallin, G S Bienvenu, E Cook, et al.Pageof 3